JIJunsuke Igarashi

Junsuke Igarashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Junsuke Igarashi has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Takeshi Hashimoto

    Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University, Kita-Gun, Japan

    6 shared publications
  • Hiroaki Kosaka

    Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University 1750-1 Ikenobe, Miki-Cho, Kita-Gun, Kagawa, 761-0793, Japan

    5 shared publications
  • Yasuo Kubota

    Department of Dermatology, Faculty of Medicine, Kagawa University, Kita-gun, Japan

    5 shared publications
  • Ikuko Tsukamoto

    Department of Pharmaco-bio-informatics, Faculty of Medicine, Kagawa University, Kita-gun, Japan

    4 shared publications
  • Kazuyo Shoji

    Department of Dermatology, Faculty of Medicine, Kagawa University 1750-1 Ikenobe, Miki-Cho, Kita-Gun, Kagawa, 761-0793, Japan

    3 shared publications
  • Kozo Yoneda

    Department of Dermatology, Kagawa University, Kagawa, Japan; and

    2 shared publications

Latest Publications

  • Open Access

    A key role of PGC-1α transcriptional coactivator in production of VEGF by a novel angiogenic agent COA-Cl in cultured human fibroblasts

    by Junsuke Igarashi, Ryuji Okamoto, Tetsuo Yamashita, Takeshi Hashimoto, Sakiko Karita, Kozo Nakai, Yasuo Kubota, Maki Takata, Fuminori Yamaguchi, Masaaki Tokuda, et al.

    We previously demonstrated a potent angiogenic effect of a newly developed adenosine‐like agent named COA‐Cl. COA‐Cl exerted tube forming activity in human umbilical vein endothelial cells in the presence of normal human dermal fibroblasts (NHDF). We therefore explored whether and how COA‐Cl modulates gene expression and protein secretion of VEGF, a master regulator of angiogenesis, in NHDF. RT‐PCR and ELISA revealed that COA‐Cl upregulated VEGF mRNA expression and protein secretion in NHDF. HIF1α (hypoxia‐inducible factor 1α), a transcription factor, and PGC‐1α (peroxisome proliferator‐activated receptor‐γ coactivator‐1α), a transcriptional coactivator, are known to positively regulate the VEGF gene. Immunoblot and RT‐PCR analyses revealed that COA‐Cl markedly upregulated the expression of PGC‐1α protein and mRNA. COA‐Cl had no effect on the expression of HIF1α protein and mRNA in both hypoxia and normoxia. Silencing PGC‐1α gene, but not HIF1α gene, by small interfering RNA attenuated the ability of COA‐Cl to promote VEGF secretion. When an N‐terminal fragment of PGC‐1α was cotransfected with its partner transcription factor ERRα (estrogen‐related receptor‐α) in COS‐7 cells, COA‐Cl upregulated the expression of the endogenous VEGF mRNA. However, COA‐Cl had no effect on the expression of VEGF, when HIF1α was transfected. COA‐Cl induces VEGF gene expression and protein secretion in fibroblasts. The transcriptional coactivator PGC‐1α, in concert with ERRα, plays a key role in the COA‐Cl‐induced VEGF production. COA‐Cl‐induced activation of PGC‐1α‐ERRα‐VEGF pathway has a potential as a novel means for therapeutic angiogenesis.


  • Open Access

    Involvement of S1P1receptor pathway in angiogenic effects of a novel adenosine‐like nucleic acid analogCOA‐Cl in cultured human vascular endothelial cells

    by Junsuke Igarashi, Takeshi Hashimoto, Yasuo Kubota, Kazuyo Shoji, Tokumi Maruyama, Norikazu Sakakibara, Yoh Takuwa, Yoshihiro Ujihara, Yuki Katanosaka, Satoshi Mohri, et al.

    COA‐Cl (2Cl‐C.OXT‐A) is a recently developed adenosine‐like nucleic acid analog that promotes angiogenesis via the mitogen‐activated protein (MAP) kinasesERK1/2. Endothelial S1P1receptor plays indispensable roles in developmental angiogenesis. In this study, we examined the functions of S1P1inCOA‐Cl‐induced angiogenic responses. Antagonists for S1P1, W146, andVPC23019, substantially but still partly inhibited the effects ofCOA‐Cl with regard toERK1/2 activation and tube formation in cultured human umbilical vein endothelial cells (HUVEC). Antagonists for adenosine A1receptor and purinergic P2Y1receptor were without effect. Genetic knockdown of S1P1with siRNA, but not that of S1P3, attenuatedCOA‐Cl‐elicitedERK1/2 responses. The signaling properties ofCOA‐Cl showed significant similarities to those of sphingosine 1‐phosphate, an endogenous S1P1ligand, in that both induced responses sensitive to pertussis toxin (Gαi/o inhibitor), 1,2‐bis(2‐aminophenoxy)ethane‐N,N,N',N'‐tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA‐AM), (calcium chelator), andPP2 (c‐Src tyrosine kinase inhibitor).COA‐Cl elevated intracellular Ca2+concentration and induced tyrosine phosphorylation of p130Cas, a substrate of c‐Src, inHUVEC.COA‐Cl displaced [3H]S1P in a radioligand‐binding competition assay in chem‐1 cells overexpressing S1P1. However,COA‐Cl activatedERK1/2 inCHO‐K1 cells that lack functional S1P1receptor, suggesting the presence of additional yet‐to‐be‐definedCOA‐Cl target in these cells. The results thus suggest the major contribution of S1P1in the angiogenic effects ofCOA‐Cl. However, other mechanism such as that seen inCHO‐K1 cells may also be partly involved. Collectively, these findings may lead to refinement of the design of this nucleic acid analog and ultimately to development of small molecule‐based therapeutic angiogenesis.


  • Dexamethasone induces caveolin-1 in vascular endothelial cells: implications for attenuated responses to VEGF

    by Junsuke Igarashi, Takeshi Hashimoto, Kazuyo Shoji, Kozo Yoneda, Ikuko Tsukamoto, Tetsuya Moriue, Yasuo Kubota, Hiroaki Kosaka

    Steroids exert direct actions on cardiovascular cells, although underlying molecular mechanisms remain incompletely understood. We examined if steroids modulate abundance of caveolin-1, a regulatory protein of cell-surface receptor pathways that regulates the magnitudes of endothelial response to vascular endothelial growth factor (VEGF). Dexamethasone, a synthetic glucocorticoid, induces caveolin-1 at both levels of protein and mRNA in a time- and dose-dependent manner in pharmacologically relevant concentrations in cultured bovine aortic endothelial cells. Aldosterone, a mineralocorticoid, but not the sex steroids 17β-estradiol, testosterone, or progesterone, elicits similar caveolin-1 induction. Caveolin-1 induction by dexamethasone and that by aldosterone were abrogated by RU-486, an inhibitor of glucocorticoid receptor, and by spironolactone, a mineralocorticoid receptor inhibitor, respectively. Dexamethasone attenuates VEGF-induced responses at the levels of protein kinases Akt and ERK1/2, small-G protein Rac1, nitric oxide production, and migration. When induction of caveolin-1 by dexamethasone is attenuated either by genetically by transient transfection with small interfering RNA or pharmacologically by RU-486, kinase responses to VEGF are rescued. Dexamethasone also increases expression of caveolin-1 protein in cultured human umbilical vein endothelial cells, associated with attenuated tube formation responses of these cells when cocultured with normal fibroblasts. Immunohistochemical analyses revealed that intraperitoneal injection of dexamethasone induces endothelial caveolin-1 protein in thoracic aorta and in lung artery in healthy male rats. Thus steroids functionally attenuate endothelial responses to VEGF via caveolin-1 induction at the levels of signal transduction, migration, and tube formation, identifying a novel point of cross talk between nuclear and cell-surface receptor signaling pathways.


  • Open Access

    Transforming growth factor-β1 downregulates caveolin-1 expression and enhances sphingosine 1-phosphate signaling in cultured vascular endothelial cells

    by Junsuke Igarashi, Kazuyo Shoji, Takeshi Hashimoto, Tetsuya Moriue, Kozo Yoneda, Tomoko Takamura, Tetsuo Yamashita, Yasuo Kubota, Hiroaki Kosaka, Ikuko Tsukamoto, et al.

    In vascular endothelial cells, specialized microdomains of plasma membrane termed caveolae modulate various receptor signal transduction pathways regulated by caveolin-1, a resident protein of caveolae. We examined whether transforming growth factor-β1 (TGF-β1), a multifunctional cytokine, alters expression levels of caveolin-1 and influences heterologous receptor signaling. Treatment of cultured bovine aortic endothelial cells (BAEC) with TGF-β1 induces marked decreases in caveolin-1 expression in a time- and dose-dependent fashion at both levels of protein and mRNA. A pharmacological inhibitor of activin receptor-like kinase 5 (ALK-5) counteracts caveolin-1 downregulation by TGF-β1, indicating the involvement of ALK-5 receptor subtype for TGF-β1. Sphingosine 1-phosphate (S1P) is a serum-borne angiogenic lipid growth factor that exerts a wide variety of biological actions. S1P modulates G protein-coupled S1P receptors, activating downstream molecules kinases AMP-activated protein kinase (AMPK), and Akt as well as a small G protein Rac1, ultimately to promote migration. Because S1P receptor signaling is associated with caveolae/caveolin-1, we examined whether pretreatment with TGF-β1 enhances effects of S1P on BAEC. Whereas S1P alone evokes robust BAEC responses to S1P, pretreatment with TGF-β1 leads to even higher magnitudes of S1P-elicited signaling responses and cell migration. Conversely, genetic knockdown of caveolin-1 using small interfering RNA mimics TGF-β1-induced promotion of BAEC responses to S1P. Collectively, these data demonstrate that TGF-β1 downregulates caveolin-1 of cultured endothelial cells, involving ALK-5 receptor subtype. Because downregulation of caveolin-1 by TGF-β1 promotes subsequent heterologous receptor signaling by S1P, these results may also identify novel point of cross-talk between cytokines and sphingolipids within endothelial signal transduction machineries.


  • Open Access

    Sphingosine kinase is induced in mouse 3T3-L1 cells and promotes adipogenesis

    by Takeshi Hashimoto, Junsuke Igarashi, Hiroaki Kosaka


  • Open Access

    Sphingosine-1-phosphate and modulation of vascular tone

    by Junsuke Igarashi, Thomas Michel

    Sphingosine-1-phosphate (S1P) is a phosphorylated product of sphingosine, the core structure of the class of lipids termed sphingolipids. S1P is a naturally occurring lipid metabolite, and usually is present at a concentration of a few 100 nanomolar in human sera. S1P has been found to exert a diverse set of physiological and pathophysiological responses in mammalian tissues through the activation of heterotrimeric G-proteins that in turn modulate the activity of various downstream effecter molecules. In blood vessels, vascular endothelial cells and smooth muscle cells express specific receptors for S1P that modulate vascular tone. This article will provide a brief overview of S1P metabolism in the vasculature and will discuss some of the pathways whereby S1P regulates intracellular signal transduction pathways in endothelial and smooth muscle cells, leading to the activation of both vasorelaxation and vasoconstriction responses.


  • Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high‐density lipoproteins

    by J Igarashi, M Miyoshi, T Hashimoto, Y Kubota, H Kosaka

    Background and purpose: Sphingosine 1‐phosphate (S1P) is a serum‐borne naturally occurring sphingolipid, specifically enriched in high‐density lipoprotein (HDL) fractions. S1P binds to G‐protein‐coupled S1P1 receptors to activate endothelial NO synthase (eNOS) in vascular endothelial cells. We explored whether and how statins, 3‐hydroxy‐3‐methylglutaryl coenzyme A (HMG‐CoA) reductase inhibitors, modulate expression of S1P1 receptors and endothelial responses for subsequent stimulation with S1P or with HDL.Experimental approach: Protein expression and phosphorylation and mRNA expression in cultured bovine aortic endothelial cells (BAEC) were determined using immunoblots and reverse transcription PCR analyses, respectively. NO synthesis was assessed as nitrite production.Key results: Stimulation of BAEC with pitavastatin or atorvastatin led to significant increases in S1P1‐receptors, at levels of protein and mRNA, in a dose‐dependent manner. When BAEC were treated with pitavastatin prior to stimulation with S1P or with normal human HDL, phosphorylation and activation of eNOS evoked by S1P or by HDL was enhanced. These effects of statins were counteracted by L‐mevalonate and were mimicked by an inhibitor of geranylgeranyl transferase I, suggesting that inhibition of HMG‐CoA reductase activity and subsequent decreases in protein geranylgeranylation may contribute to these actions of statins. Specific knock down of S1P1 receptors by small interfering RNA led to attenuation of eNOS responses to HDL.Conclusions and implications: Statins induce S1P1 receptors and potentiate responses of endothelial cells to HDL‐associated sphingolipids, identifying a novel aspect of the pleiotropic actions of statins through which they may exert NO‐dependent vascular protective effects.British Journal of Pharmacology (2007) 150, 470–479. doi:10.1038/sj.bjp.0707114


  • Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediator

    by Junsuke Igarashi, Megumi Miyoshi, Takeshi Hashimoto, Yasuo Kubota, Hiroaki Kosaka

    Sphingosine 1-phosphate (S1P) is a platelet-derived angiogenic lipid growth factor, modulating G-protein-coupled S1P1 receptors (S1P1-R) to activate endothelial nitric oxide synthase (eNOS), as well as MAPK pathways in endothelial cells. We explored whether and how hydrogen peroxide (H2O2), a representative reactive oxygen species, alters S1P1-R expression and influences S1P signaling in cultured bovine aortic endothelial cells (BAECs). When BAECs are treated with pathophysiologically relevant concentrations of H2O2 (150 μM for 30 min), S1P1-R protein expression levels are acutely augmented by ∼30-fold in a dose-dependent fashion. When BAECs have been pretreated with H2O2, subsequent S1P stimulation (100 nM) leads to a higher degree of eNOS enzyme activation (assessed as intracellular cGMP content, 1.7 ± 0.2-fold vs. no H2O2 pretreatment groups, P < 0.05), associated with a higher magnitude of phosphorylation responses of eNOS and MAPK ERK1/2. PP2, an inhibitor of Src-family tyrosine kinase, abolished the effects of H2O2 on both S1P1-R protein upregulation and enhanced BAEC responses to S1P. H2O2 does not augment S1P1 mRNA expression, whereas VEGF under identical cultures leads to increases in S1P1 mRNA signals. Whereas H2O2 attenuates proliferation of BAECs, addition of S1P restores growth responses of these cells. These results demonstrate that extracellularly administered H2O2 increases S1P1-R expression and promotes endothelial responses for subsequent S1P treatment. These results may identify potentially important points of cross-talk between reactive oxygen species and sphingolipid pathways in vascular responses.